Ramiro Martin Cabral
CIK 1752437 · View on SEC EDGAR ↗
First SEC filing: March 3, 2021 · Latest: March 3, 2021
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 11, 2019 | ELAN | P | 1,227 | — | — | 12,741 Direct | +10.66% | Acquired | (price as of 2026-08-20) |
| Sept. 24, 2018 | ELAN | P | 1,000 | $24.00 | $24,000 | 1,000 Direct | — | Acquired | 0.9% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 1, 2023 | ELAN | Employee Stock Option (right to buy) | Common Stock (86,207) | $11.26 | March 1, 2033 | 86,207 | Acquired |
| March 1, 2022 | ELAN | Employee Stock Option(right to buy) | Common Stock (33,747) | $28.94 | March 1, 2032 | 33,747 | Acquired |
| Oct. 20, 2018 | ELAN | Non-Qualified Stock Option (Right-to-Buy) | Elanco Animal Health Inc. Common Stock (21,086) | $31.61 | Oct. 20, 2028 | 21,086 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
ELAN
President International| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $650,000 | — | — | — | $566,800 | — | $26,952 | $3,243,767 |
| 2024 | $620,000 | — | — | — | $478,950 | — | $28,501 | $2,942,471 |
| 2023 | $592,000 | — | — | — | $327,376 | — | $31,362 | $2,650,754 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.